Review



streptococcus mutans  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    ATCC streptococcus mutans
    Streptococcus Mutans, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r2+9a5/R2-9A5/us12161689-778-51-48
    Average 93 stars, based on 16 article reviews
    streptococcus mutans - by Bioz Stars, 2026-08
    93/100 stars

    Images



    Similar Products

    93
    ATCC streptococcus mutans
    Streptococcus Mutans, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r2+9a5/R2-9A5/us12161689-778-51-48
    Average 93 stars, based on 1 article reviews
    streptococcus mutans - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    94
    Bio X Cell r2 9a5
    Reagents and tools table
    R2 9a5, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r2+9a5/InVivoMAb+anti-mouse+IL-12+p75/pmc12048687-39-8-5
    Average 94 stars, based on 1 article reviews
    r2 9a5 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    90
    Bio X Cell anti-mouse il-12p75 clone r2-9a5
    Reagents and tools table
    Anti Mouse Il 12p75 Clone R2 9a5, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r2+9a5/anti+il+12p70+r2+9a5/pm36635335-504-8-13
    Average 90 stars, based on 1 article reviews
    anti-mouse il-12p75 clone r2-9a5 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    93
    ATCC pta 2357
    Reagents and tools table
    Pta 2357, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r2+9a5/R2-9A5/us11623953-723-21-33
    Average 93 stars, based on 1 article reviews
    pta 2357 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    95
    Bio X Cell ail12 clone r2 9a5 bioxcell cat
    Reagents and tools table
    Ail12 Clone R2 9a5 Bioxcell Cat, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r2+9a5/InVivoMAb+anti-mouse+CXCR3/pm36223746-144-47-50
    Average 95 stars, based on 1 article reviews
    ail12 clone r2 9a5 bioxcell cat - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    90
    Bio X Cell ant-il-12 (p70) (r2-9a5) antibody
    (A and B) Groups of C57BL/6 and TLR-deficient mice infected with LD or HD Lm Δ actA -Ova. (A) Absolute number of Ova-specific CD8 + T cells at day 7 post-infection with HD Lm Δ actA -Ova compared among splenic isolates of Tlr2 −/− , Tlr4 −/− , Tlr7 −/− , and Tlr9 M7Btlr mice (n = 6–10 per group). (B) Absolute number of Ova-specific CD8 + T cells at day 7 in the spleens of Tlr9 M7Btlr mice ± CD4 + T cell depletion (n = 6–8 per group). (C and D) Groups of C57BL/6 and Tlr9 M7Btlr mice systemically infected with HD Lm Δ actA -Ova. (C) Fold change in serum cytokines and chemokines from 0–6 h post-infection. (D) Selected serum cytokine/chemokine concentration at 6 h post-infection displaying significance in (C) (n = 6 per group). (E) Foxp3 EGFP mice infected with HD Lm Δ actA -Ova for 24 h. Ingenuity Pathway Analysis (IPA) upstream regulator prediction of differential gene expression profiles comparing total FoxP3-EGFP + T reg sorted from naive versus infected mice (top 50 significant hits; p = gene network overlap) (n = 4 per group). (F) Kinetic display of IFN-a2/4, IFN-b, IFN-g, and IL-12 <t>(p70)</t> serum concentration in C57BL/6 and Tlr9 M7Btlr mice after exposure to HD Lm D actA -Ova (n = 6 per group).
    Ant Il 12 (P70) (R2 9a5) Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r2+9a5/anti+il+12p70+r2+9a5/pmc08903023-27-0-4
    Average 90 stars, based on 1 article reviews
    ant-il-12 (p70) (r2-9a5) antibody - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    94
    Bio X Cell il 12 p75 r2 9a5
    (A and B) Groups of C57BL/6 and TLR-deficient mice infected with LD or HD Lm Δ actA -Ova. (A) Absolute number of Ova-specific CD8 + T cells at day 7 post-infection with HD Lm Δ actA -Ova compared among splenic isolates of Tlr2 −/− , Tlr4 −/− , Tlr7 −/− , and Tlr9 M7Btlr mice (n = 6–10 per group). (B) Absolute number of Ova-specific CD8 + T cells at day 7 in the spleens of Tlr9 M7Btlr mice ± CD4 + T cell depletion (n = 6–8 per group). (C and D) Groups of C57BL/6 and Tlr9 M7Btlr mice systemically infected with HD Lm Δ actA -Ova. (C) Fold change in serum cytokines and chemokines from 0–6 h post-infection. (D) Selected serum cytokine/chemokine concentration at 6 h post-infection displaying significance in (C) (n = 6 per group). (E) Foxp3 EGFP mice infected with HD Lm Δ actA -Ova for 24 h. Ingenuity Pathway Analysis (IPA) upstream regulator prediction of differential gene expression profiles comparing total FoxP3-EGFP + T reg sorted from naive versus infected mice (top 50 significant hits; p = gene network overlap) (n = 4 per group). (F) Kinetic display of IFN-a2/4, IFN-b, IFN-g, and IL-12 <t>(p70)</t> serum concentration in C57BL/6 and Tlr9 M7Btlr mice after exposure to HD Lm D actA -Ova (n = 6 per group).
    Il 12 P75 R2 9a5, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/r2+9a5/InVivoMAb+anti-mouse+IL-12+p75/pmc07741883-118-24-28
    Average 94 stars, based on 1 article reviews
    il 12 p75 r2 9a5 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    Image Search Results


    Reagents and tools table

    Journal: The EMBO Journal

    Article Title: T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses

    doi: 10.1038/s44318-025-00414-3

    Figure Lengend Snippet: Reagents and tools table

    Article Snippet: InVivoMab α-IL-12 blocking antibody , BioXcell , Clone R2-9A5 #BE0233.

    Techniques: Transgenic Assay, Mouse Assay, Recombinant, Blocking Assay, Control, Staining, Sequencing, Expressing, Derivative Assay, Lysis, Software, Cell Isolation, Microscopy, Real-time Polymerase Chain Reaction

    (A and B) Groups of C57BL/6 and TLR-deficient mice infected with LD or HD Lm Δ actA -Ova. (A) Absolute number of Ova-specific CD8 + T cells at day 7 post-infection with HD Lm Δ actA -Ova compared among splenic isolates of Tlr2 −/− , Tlr4 −/− , Tlr7 −/− , and Tlr9 M7Btlr mice (n = 6–10 per group). (B) Absolute number of Ova-specific CD8 + T cells at day 7 in the spleens of Tlr9 M7Btlr mice ± CD4 + T cell depletion (n = 6–8 per group). (C and D) Groups of C57BL/6 and Tlr9 M7Btlr mice systemically infected with HD Lm Δ actA -Ova. (C) Fold change in serum cytokines and chemokines from 0–6 h post-infection. (D) Selected serum cytokine/chemokine concentration at 6 h post-infection displaying significance in (C) (n = 6 per group). (E) Foxp3 EGFP mice infected with HD Lm Δ actA -Ova for 24 h. Ingenuity Pathway Analysis (IPA) upstream regulator prediction of differential gene expression profiles comparing total FoxP3-EGFP + T reg sorted from naive versus infected mice (top 50 significant hits; p = gene network overlap) (n = 4 per group). (F) Kinetic display of IFN-a2/4, IFN-b, IFN-g, and IL-12 (p70) serum concentration in C57BL/6 and Tlr9 M7Btlr mice after exposure to HD Lm D actA -Ova (n = 6 per group).

    Journal: Cell reports

    Article Title: TLR9 Sensing of Self-DNA Controls Cell-Mediated Immunity to Listeria Infection via Rapid Conversion of Conventional CD4 + T Cells to T reg

    doi: 10.1016/j.celrep.2020.01.040

    Figure Lengend Snippet: (A and B) Groups of C57BL/6 and TLR-deficient mice infected with LD or HD Lm Δ actA -Ova. (A) Absolute number of Ova-specific CD8 + T cells at day 7 post-infection with HD Lm Δ actA -Ova compared among splenic isolates of Tlr2 −/− , Tlr4 −/− , Tlr7 −/− , and Tlr9 M7Btlr mice (n = 6–10 per group). (B) Absolute number of Ova-specific CD8 + T cells at day 7 in the spleens of Tlr9 M7Btlr mice ± CD4 + T cell depletion (n = 6–8 per group). (C and D) Groups of C57BL/6 and Tlr9 M7Btlr mice systemically infected with HD Lm Δ actA -Ova. (C) Fold change in serum cytokines and chemokines from 0–6 h post-infection. (D) Selected serum cytokine/chemokine concentration at 6 h post-infection displaying significance in (C) (n = 6 per group). (E) Foxp3 EGFP mice infected with HD Lm Δ actA -Ova for 24 h. Ingenuity Pathway Analysis (IPA) upstream regulator prediction of differential gene expression profiles comparing total FoxP3-EGFP + T reg sorted from naive versus infected mice (top 50 significant hits; p = gene network overlap) (n = 4 per group). (F) Kinetic display of IFN-a2/4, IFN-b, IFN-g, and IL-12 (p70) serum concentration in C57BL/6 and Tlr9 M7Btlr mice after exposure to HD Lm D actA -Ova (n = 6 per group).

    Article Snippet: ant-IL-12 (p70) (R2-9A5) , BioXCell , Cat#BE0233.

    Techniques: Infection, Concentration Assay, Gene Expression

    (A) C57BL/6 mice administered 50 μg CpG-A, CpG-B, and CpG control ODNs at days −1 and 0. Frequency of splenic CD25 + FoxP3 + CD4 + T reg and change in FoxP3 + :FoxP3 − CD4 + T cell ratio relative to CpG controls (D FoxP3 + :FoxP3 − ) at day 1 (n = 4 per group). (B) C57BL/6 and Foxp3 DTR-EGFP mice administered CpG ODNs as in (A) and infected with LD Lm Δ actA -Ova at day 0 and co-delivered a complete DT regimen. Absolute number of splenic Ova-specific CD8 + T cells at day 7 post-infection (n = 6 per group). (C) Splenic Ova-specific CD8 + T cell response observed in CpG-treated or -infected C57BL/6 as in (B), with blockade of IL-12 (p70) (n = 4 per group). (D) Quantification of mtDNA ( 12 s and Trlev ), nDNA ( Neb and Becn1 ), and Lm DNA ( Ova , mpl , and plcB ) in cell- and RNA-free serum samples after HD Lm Δ actA - Ova infection of C57BL/6 mice (n = 6 per group). (E) Serum ALT concentration within LD versus HD Lm Δ actA -Ova-infected C57BL/6 mice (n = 6 per group). (F) Effect of neutrophil depletion before HD Lm Δ actA -Ova infection of C57BL/6 mice on mtDNA ( 12 s and Trlev ) in cell- and RNA-free serum samples isolated at 4 h post-infection (n = 6 per group). (G) Absolute number of splenic Ova-specific CD8 + T cells at day 7 post-infection in C57BL/6 and Foxp3 DTR-EGFP mice administered a complete DT regimen, systemic HD Lm Δ actA -Ova, and selective DNase I delivery (n = 4 per group). (H) Survival of untreated versus DNase I-treated C57BL/6 mice infected with WT Lm Ova (n = 10–16 per group). (I and J) In vitro co-expression of FoxP3 and T-bet in conventional CD4 + EGFP − T cells isolated from Foxp3 EGFP or Il12rb2 −/− Foxp3 EGFP mice cultured in the presence or absence of CD3/CD28-mediated activation, rmTGF-b1, and rmIL-12 (p70) (n = 4 per group).

    Journal: Cell reports

    Article Title: TLR9 Sensing of Self-DNA Controls Cell-Mediated Immunity to Listeria Infection via Rapid Conversion of Conventional CD4 + T Cells to T reg

    doi: 10.1016/j.celrep.2020.01.040

    Figure Lengend Snippet: (A) C57BL/6 mice administered 50 μg CpG-A, CpG-B, and CpG control ODNs at days −1 and 0. Frequency of splenic CD25 + FoxP3 + CD4 + T reg and change in FoxP3 + :FoxP3 − CD4 + T cell ratio relative to CpG controls (D FoxP3 + :FoxP3 − ) at day 1 (n = 4 per group). (B) C57BL/6 and Foxp3 DTR-EGFP mice administered CpG ODNs as in (A) and infected with LD Lm Δ actA -Ova at day 0 and co-delivered a complete DT regimen. Absolute number of splenic Ova-specific CD8 + T cells at day 7 post-infection (n = 6 per group). (C) Splenic Ova-specific CD8 + T cell response observed in CpG-treated or -infected C57BL/6 as in (B), with blockade of IL-12 (p70) (n = 4 per group). (D) Quantification of mtDNA ( 12 s and Trlev ), nDNA ( Neb and Becn1 ), and Lm DNA ( Ova , mpl , and plcB ) in cell- and RNA-free serum samples after HD Lm Δ actA - Ova infection of C57BL/6 mice (n = 6 per group). (E) Serum ALT concentration within LD versus HD Lm Δ actA -Ova-infected C57BL/6 mice (n = 6 per group). (F) Effect of neutrophil depletion before HD Lm Δ actA -Ova infection of C57BL/6 mice on mtDNA ( 12 s and Trlev ) in cell- and RNA-free serum samples isolated at 4 h post-infection (n = 6 per group). (G) Absolute number of splenic Ova-specific CD8 + T cells at day 7 post-infection in C57BL/6 and Foxp3 DTR-EGFP mice administered a complete DT regimen, systemic HD Lm Δ actA -Ova, and selective DNase I delivery (n = 4 per group). (H) Survival of untreated versus DNase I-treated C57BL/6 mice infected with WT Lm Ova (n = 10–16 per group). (I and J) In vitro co-expression of FoxP3 and T-bet in conventional CD4 + EGFP − T cells isolated from Foxp3 EGFP or Il12rb2 −/− Foxp3 EGFP mice cultured in the presence or absence of CD3/CD28-mediated activation, rmTGF-b1, and rmIL-12 (p70) (n = 4 per group).

    Article Snippet: ant-IL-12 (p70) (R2-9A5) , BioXCell , Cat#BE0233.

    Techniques: Control, Infection, Concentration Assay, Isolation, In Vitro, Expressing, Cell Culture, Activation Assay

    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: TLR9 Sensing of Self-DNA Controls Cell-Mediated Immunity to Listeria Infection via Rapid Conversion of Conventional CD4 + T Cells to T reg

    doi: 10.1016/j.celrep.2020.01.040

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: ant-IL-12 (p70) (R2-9A5) , BioXCell , Cat#BE0233.

    Techniques: Virus, Recombinant, Enzyme-linked Immunosorbent Assay, Staining, Gene Expression, Software, Luminex